Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Mednow Inc. MDNWF OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • CA • USD

SharesGrow Score
18/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Mednow Inc. (MDNWF) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.02. It has a SharesGrow Score of 17/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $17M, +3919%/yr average growth. Net income is $29M (loss), growing at -1018.2%/yr. Net profit margin is -177.2% (negative). Gross margin is 16.7% (-83.3 pp trend).

Balance sheet: total debt is $7M against $6M equity (Debt-to-Equity (D/E) ratio 1.15, moderate). Current ratio is 0.99 (tight liquidity). Debt-to-assets is 38.6%. Total assets: $18M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 17/100 (Fail), Moat 7/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

MDNWF SharesGrow Score Overview

23/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 7/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — MDNWF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
MDNWF: +3919%/yr revenue is, -1018.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
17/100
Balance sheet MDNWF: Debt-to-Equity (D/E) ratio 1.15 (moderate), Current ratio is 0.99 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
7/100
MDNWF: Gross margin is 16.7% (-83.3 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 7/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
MDNWF: Net profit margin is -177.2%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.02
Volume7.5K
Avg Volume (30D)3.37K
Market Cap$517.29K
Beta (1Y)1.62
Share Statistics
EPS (TTM)-1.37
Shares Outstanding$21.57M
IPO Date2021-07-09
CEOSimranveer Grewal
Financial Highlights & Ratios
Revenue (TTM)$16.64M
Gross Profit$2.78M
EBITDA$-19.85M
Net Income$-29.48M
Operating Income$-19.69M
Total Cash$4.97M
Total Debt$7M
Net Debt$2.03M
Total Assets$18.13M
Price / Earnings (P/E)-0
Price / Sales (P/S)0.03
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA58503L2021

Price Chart

Track all markets on TradingView
MDNWF
Mednow Inc. ↗  ·  Other OTC
Healthcare • Medical - Healthcare Information Services
0.00 52WK RANGE 0.02

People Also View

LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
 RHHBY
RHHBY
Roche Holding AG
$50.99
-0.08%
 AZN
AZN
AstraZeneca PLC
$201.21
-1.55%
 NVS
NVS
Novartis AG
$152.08
-0.85%
 MRK
MRK
Merck & Co., Inc.
$117.90
-1.72%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message